Dr Philip Currie Joins ResApp’s Scientific Advisory Board

View printer-friendly version ResApp Health Limited (ASX:RAP), a leading digital health company developing smartphone applications for the diagnosis and management of respiratory disease, is pleased to announce the appointment of Dr Philip Currie to its Scientific...

ResApp Receives R&D Tax Incentive Cash Refund for FY16

View printer-friendly version ResApp Health Limited (ASX:RAP), a leading digital health company developing smartphone applications for the diagnosis and management of respiratory disease, is pleased to announce that is has received a cash refund of $516,305 from its...